The University of Queensland

Complement C3a receptor, a novel therapeutic target for melanoma (2014–2015)

Grant type:

Cancer Council Queensland

Researchers:

• 

  Associate Professor Barbara Rolfe

  Principal Research Fellow and GL
  

  Australian Institute for Bioengineering and Nanotechnology

• 

  Professor Andrew Barbour

  Professor
  

  Princess Alexandra Hospital Southside Clinical Unit

  Faculty of Medicine

Funded by:

Cancer Council Queensland